Coronary Disease: all 2,867 studies

Page 5 of 29. Open to participants first (309), then studies with results posted, then the rest; newest registration first within each.

• Genetic Risk and Health Coaching for Type 2 Diabetes and Coronary Heart DiseaseCompletedNCT01884545Not applicableResults posted
• A Study to Assess the Effectiveness and Safety of Rivaroxaban in Reducing the Risk of Death, Myocardial Infarction or Stroke in Participants With Heart Failure and Coronary Artery Disease Following an Episode of Decompensated Heart FailureCompletedNCT01877915Phase 3Results posted
• Pharmacodynamic Effect of Prasugrel vs. Ticagrelor in DiabetesCompletedNCT01852214Not applicableResults posted
• Pharmacodynamic Effects of Prasugrel Compared With Ticagrelor in Patients With Coronary Artery DiseaseCompletedNCT01852175Not applicableResults posted
• Pharmacodynamic Effects of Dabigatran in Patients on Dual Antiplatelet TherapyCompletedNCT01852162Not applicableResults posted
• Cangrelor Prasugrel Transition StudyCompletedNCT01852019Phase 2Results posted
• AVJ-301 Clinical Trial: A Clinical Evaluation of AVJ-301 (Absorb™ BVS) in Japanese PopulationCompletedNCT01844284Not applicableResults posted
• YELLOW II Study: Reduction in Coronary Yellow Plaque, Lipids and Vascular Inflammation by Aggressive Lipid LoweringCompletedNCT01837823Phase 2Results posted
• Ticagrelor Versus Clopidogrel in Type 2 Diabetic PatientsCompletedNCT01823510Phase 4Results posted
• Impact of Ranolazine on Coronary Microcirculatory ResistanceCompletedNCT01815957Not applicableResults posted
• Cangrelor Ticagrelor Transition StudyCompletedNCT01766466Phase 2Results posted
• Evaluation of HealinG of Polymer-Free Biomlimus A9-Coated Stent by Optical Coherence Tomography (EGO-BIOFREEDOM)CompletedNCT01760876Not applicableResults posted
• ABSORB FIRST is a Registry Designed to Evaluate the Safety and Performance of Absorb Bioresorbable Vascular Scaffold (Absorb BVS) Used in Real-world Patients.CompletedNCT01759290Results posted
• HeartFlowNXT - HeartFlow Analysis of Coronary Blood Flow Using Coronary CT AngiographyCompletedNCT01757678Not applicableResults posted
• Effects of Ranolazine on Coronary Flow Reserve in Symptomatic Diabetic Patients and CADCompletedNCT01754259Phase 3Results posted
• ABSORB III Randomized Controlled Trial (RCT)CompletedNCT01751906Not applicableResults posted
• The Clinical Diagnosis Meaning of MIF in Coronary Heart DiseaseCompletedNCT01750502Results posted
• Clinical Evaluation of the CADence Device in Detection of Coronary Artery DiseasesCompletedNCT01743040Results posted
• Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation PatientsCompletedNCT01710254Phase 2Results posted
• A Lifestyle Physical Activity Intervention for Older Sedentary WomenCompletedNCT01707693Not applicableResults posted
• A Clinical Evaluation of ST Changes in a Group of Patients Having Ventricular ArrhythmiasCompletedNCT01685047Results posted
• Custodiol-HTK (Histidine-tryptophan-ketoglutarate) Solution as a Cardioplegic AgentCompletedNCT01681095Phase 2Results posted
• Clinical Evaluation of Magnetic Resonance Imaging in Coronary Heart Disease-2CompletedNCT01664858Not applicableResults posted
• Translating a Heart Disease Lifestyle Intervention Into the CommunityCompletedNCT01647438Not applicableResults posted
• An Evaluation of the Commercially Available Medtronic Resolute Integrity Zotarolimus-Eluting Coronary Stent SystemCompletedNCT01638507Not applicableResults posted
• Anti-INFLammatory to Address Mood and Endothelial Dysfunction (INFLAMED)CompletedNCT01625845Phase 2Results posted
• A Study to Assess Regadenoson Administration Following an Inadequate Exercise Stress Test as Compared to Regadenoson Alone for Myocardial Perfusion Imaging (MPI) Using Single Photon Emission Computed Tomography (SPECT)CompletedNCT01618669Phase 3Results posted
• Beating the Blues for Your HeartCompletedNCT01605552Phase 2Results posted
• PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease DiagnosisCompletedNCT01594411Results posted
• Myocardial Dysfunction in Type 2 Diabetes Mellitus (T2DM)CompletedNCT01588470Phase 4Results posted
• Pharmacodynamic Evaluation of Switching From Ticagrelor to Prasugrel in Subjects With Stable Coronary Artery DiseaseCompletedNCT01587651Phase 4Results posted
• Vitamin D Repletion in Coronary Artery DiseaseCompletedNCT01570309Not applicableResults posted
• Reduction in YEllow Plaque by Aggressive Lipid LOWering TherapyCompletedNCT01567826Phase 4Results posted
• A Study of 123I-CMICE-013 Radiopharmaceutical in Healthy VolunteersCompletedNCT01558362Phase 1Results posted
• Depression Outpatient Cardiology Screening StudyCompletedNCT01552889Not applicableResults posted
• Relationship Between the Menstrual Cycle and Heart Disease in WomenCompletedNCT01546454Not applicableResults posted
• A Pharmacodynamic Study With Ticagrelor in African American PatientsCompletedNCT01523392Phase 4Results posted
• A Pharmacodynamic Study With Ticagrelor in Hispanic PatientsCompletedNCT01523366Phase 4Results posted
• Efficacy and Safety of Targeted Intramyocardial Delivery of Auto CD34+ Stem Cells for Improving Exercise Capacity in Subjects With Refractory AnginaCompletedNCT01508910Phase 3Results posted
• Regadenoson Real Time Perfusion Imaging Trial-OptisonCompletedNCT01489176Phase 3Results posted
• Efficacy of LCQ908 on Cardiovascular RiskTerminatedNCT01474434Phase 2Results posted
• International Study of Comparative Health Effectiveness With Medical and Invasive Approaches (ISCHEMIA)CompletedNCT01471522Not applicableResults posted
• Health Information Technology (HIT) Enhanced Family History Documentation and Management in Primary CareCompletedNCT01468675Not applicableResults posted
• EXPERT CTO: Evaluation of the XIENCE PRIME™ LL and XIENCE Nano™ Everolimus Eluting Coronary Stent Coronary Stents, Performance, and Technique in Chronic Total OcclusionsCompletedNCT01435031Not applicableResults posted
• Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable AnginaCompletedNCT01425359Phase 4Results posted
• ABSORB II Randomized Controlled TrialCompletedNCT01425281Not applicableResults posted
• ION US Post-Approval StudyCompletedNCT01422889Results posted
• Observational Registry Study: FIREHAWK DES for Treating Coronary Artery Disease (CAD)CompletedNCT01412164Not applicableResults posted
• Aspirin Responsiveness in Women With Coronary Artery DiseaseCompletedNCT01406990Results posted
• Is Verapamil In TransRadial Interventions OmittabLe?CompletedNCT01402427Not applicableResults posted
• Research on Nicorandil Treatment of Patients Diagnosed as CHD (Coronary Heart Disease) With Stable AnginaCompletedNCT01396395Phase 4Results posted
• A Phase 3 Multi-center Study to Assess PET Imaging of Flurpiridaz F 18 Injection in Patients With CAD.CompletedNCT01347710Phase 3Results posted
• A Study of Regadenoson in Subjects Undergoing Stress Myocardial Perfusion Imaging (MPI) Using Multidetector Computed Tomography (MDCT) Compared to Single Photon Emission Computed Tomography (SPECT)CompletedNCT01334918Phase 2Results posted
• A Study of Dalcetrapib in Patients Hospitalized For An Acute Coronary Syndrome (Dal-ACUTE)CompletedNCT01323153Phase 3Results posted
• Clinical Investigation of the MiStent Drug Eluting Stent (DES) in Coronary Artery DiseaseCompletedNCT01294748Phase 2Results posted
• A Study to Assess the Safety, Tolerability, and Effects of MK-0974 (Telcagepant) on Exercise Tolerance in Patients With Stable Angina (MK-0974-014)CompletedNCT01294709Phase 1Results posted
• Investigation of the Athero-Protective Effects of ClopidogrelCompletedNCT01283282Phase 4Results posted
• Evaluation of the Safety and Effectiveness of the CorPath 200 System in Percutaneous Coronary Interventions (PCI)CompletedNCT01275092Phase 2Results posted
• Randomized Evaluation of Patients With Stable Angina Comparing Diagnostic ExaminationsTerminatedNCT01262625Not applicableResults posted
• The Influence of Smoking Status on Prasugrel and Clopidogrel Treated Subjects Taking Aspirin and Having Stable Coronary Artery DiseaseCompletedNCT01260584Phase 4Results posted
• Xenetix® 350: Comparative Assessment of Image Quality for Coronary CT AngiographyCompletedNCT01255722Phase 4Results posted
• XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval, Single-Arm StudyCompletedNCT01249027Results posted
• First-In-Human Trial of the MiStent Drug-Eluting Stent (DES) in Coronary Artery DiseaseCompletedNCT01247428Phase 2Results posted
• Determination of Fractional Flow Reserve by Anatomic Computed Tomographic AngiographyCompletedNCT01233518Not applicableResults posted
• Metformin to Reduce Heart Failure After Myocardial InfarctionCompletedNCT01217307Phase 2/3Results posted
• EXCEL Clinical TrialCompletedNCT01205776Not applicableResults posted
• Aspirin Dosing in Diabetic PatientsCompletedNCT01201785Phase 4Results posted
• Prasugrel Re-load StrategiesCompletedNCT01201772Phase 4Results posted
• Randomized MicroPort's Firehawk DES Versus Xience V: TARGET I TrialCompletedNCT01196819Not applicableResults posted
• XIENCE V Everolimus Eluting Coronary Stent System (EECSS) China: Post-Approval Randomized Control Trial (RCT)CompletedNCT01178268Phase 4Results posted
• SPIRIT V: A Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in the Treatment of Patients With de Novo Coronary Artery Lesions (Diabetic Sub-Study)CompletedNCT01171820Phase 4Results posted
• RESOLUTE Japan SVS: The Clinical Evaluation of the MDT-4107 DES in the Treatment of De Novo Lesions in Small Diameter Native Coronary ArteriesCompletedNCT01150500Not applicableResults posted
• FAME II - Fractional Flow Reserve (FFR) Guided Percutaneous Coronary Intervention (PCI) Plus Optimal Medical Treatment (OMT) Verses OMTCompletedNCT01132495Not applicableResults posted
• XIENCE V® Everolimus Eluting Coronary Stent System USA Post-Approval Study (XIENCE V® USA Long Term Follow-up Cohort)CompletedNCT01120379Results posted
• An Asian Study to Assess the Properties and Profile of Ticagrelor in Patients With Stable Coronary Artery DiseaseCompletedNCT01118325Phase 2Results posted
• A Clinical Evaluation of the XIENCE PRIME Small Vessel Everolimus Eluting Coronary Stent System in Japanese PopulationCompletedNCT01115933Not applicableResults posted
• Integrated Dual Exercise and Lexiscan Positron Emission Tomography: IDEALPETCompletedNCT01109992Phase 4Results posted
• Comparison of Prasugrel and Clopidogrel in Low Body Weight Versus Higher Body Weight With Coronary Artery DiseaseCompletedNCT01107925Phase 1Results posted
• Comparison of Prasugrel and Clopidogrel in Very Elderly and Non-Elderly Patients With Stable Coronary Artery DiseaseCompletedNCT01107912Phase 1Results posted
• XIENCE V® USA Dual Antiplatelet Therapy (DAPT) CohortCompletedNCT01106534Phase 4Results posted
• XIENCE V/PROMUS Everolimus-Eluting Stent System Post-marketing Surveillance Protocol for JapanCompletedNCT01086228Results posted
• PROMUS Element Japan Small Vessel TrialCompletedNCT01080261Phase 3Results posted
• Global Vascular Effects of Intermittent Pneumatic Compression-Pilot StudyCompletedNCT01064323Not applicableResults posted
• ABSORB EXTEND Clinical InvestigationCompletedNCT01023789Not applicableResults posted
• Effect of Vitamin D Supplement on Inflammation Markers in High-Risk Cardiovascular Patients With Chronic Kidney DiseaseTerminatedNCT01012414Phase 3Results posted
• Study On Liprimar (Atorvastatin) In Patients With Coronary Heart Disease (CHD) And High Risk Of Cardiovascular ComplicationsCompletedNCT00993915Results posted
• Stress Management and Biomarkers of Risk in Cardiac RehabilitationCompletedNCT00981253Not applicableResults posted
• Alternate Day Fasting for Weight Loss, Weight Maintenance and Cardio-protectionCompletedNCT00960505Not applicableResults posted
• ST Segment Detection StudyTerminatedNCT00930969Results posted
• Reducing Risk in Cardiac Rehabilitation: Partners Together in Health (PaTH) Intervention StudyCompletedNCT00926848Not applicableResults posted
• SPIRIT PRIME Clinical TrialCompletedNCT00916370Phase 3Results posted
• Balloon Pump Assisted Coronary Intervention StudyCompletedNCT00910481Not applicableResults posted
• Stress Testing and Cardiac Magnetic ResonanceCompletedNCT00871260Phase 4Results posted
• A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal ImpairmentCompletedNCT00863707Phase 4Results posted
• Phytosterols, Ezetimibe, and Cholesterol MetabolismCompletedNCT00863265Early Phase 1Results posted
• A Study of the Safety and Tolerance of Regadenoson in Subjects With Asthma or Chronic Obstructive Pulmonary DiseaseCompletedNCT00862641Phase 4Results posted
• Multivariable Assessment of Coronary Artery Disease Using Cardiac CT ImagingCompletedNCT00857792Not applicableResults posted
• ABSORB Clinical Investigation, Cohort BCompletedNCT00856856Not applicableResults posted
• Safety and Efficacy of Aliskiren on the Progression of Atherosclerosis in Coronary Artery Disease PatientsCompletedNCT00853827Phase 3Results posted
• Myocardial Stress Perfusion Imaging With Dual Source CTCompletedNCT00853671Not applicableResults posted

← Coronary Disease overview